Kinetic studies of the effects of Temodal and quercetin on astrocytoma cells

Pharmacological Reports

Volumn 63, Issue 2, 2011, Pages 403-416

  Jakubowicz Gil, Joanna ^a   Langner, Ewa ^b   Rzeski, Wojciech ^a,b  

^a MARIA CURIE SK ODOWSKA UNIVERSITY   (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

Astrocytoma; Caspases; Cell death; Hsps; LC3; Quercetin; Temodal

Indexed keywords

CASPASE 3; CASPASE 8; CYTOCHROME C; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 72; QUERCETIN; TEMOZOLOMIDE;

APOPTOSIS; ARTICLE; ASTROCYTOMA CELL; AUTOPHAGY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVATION; DRUG CYTOTOXICITY; DRUG EFFECT; HUMAN; HUMAN CELL; NECROSIS; PHARMACODYNAMICS; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN SECRETION;

EID: 79955938439     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(11)70506-0     Document Type: Article

References (44)

1. Azuma K, Ippoushi K, Ito H, Higashio H, Terao J: Combination of lipids and emulsifiers enhances the absorption of orally administered quercetin in rats. J Agric Food Chem, 2002, 50, 1706-1712. (Pubitemid 34233251)
2. Boulton DW, Walle UK, Walle T: Fate of the flavonoid quercetin in human cell lines: chemical instability and metabolism. J Pharm Pharmacol, 1999, 51, 353-359. (Pubitemid 29192790)
3. Brada M, Hoang-Xuuan K, Rampling R: Multicenter phase II trial of Temozolomide in patients with glioblastoma multiforme at first relapse. Ann Oncol, 2001, 12, 259-266. (Pubitemid 32223879)
4. Bradford MM: A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem, 1976, 72, 248-254.
5. Braganhol E, Zamin LL, Canedo AD, Horn F, Tamajusuku AS, Wink MR, Salbego C, Battastini AM: Antiproliferative effect of quercetin in the human U138MG glioma cell line. Anticancer Drugs, 2006, 17, 663-671. (Pubitemid 44265867)
6. Chowdhury SA, Kishino K, Satoh R, Hashimoto K, Kikuchi H, Nishikawa H, Shirataki Y, Sakagami H: Tumor-specificity and apoptosis-inducing activity of stilbenes and flavonoids. Anticancer Res, 2005, 25, 2055-2063. (Pubitemid 40904604)
7. Clark JI: Therapeutic applications of heat shock proteins and molecular chaperones. Exp Op Ther Pat, 2001, 11, 1153-1160.
8. Conquer JA, Maiani G, Azzini E, Raguzzini A, Holub BJ: Supplementation with quercetin markedly increases plasma quercetin concentration without effect on selected risk factors for heart disease in healthy subjects. J Nutr, 1998, 128, 593-597. (Pubitemid 28188358)
9. Friedman HS, Kerby T, Calvert H: Temozolomide and treatment of malignant glioma. Clin Cancer Res, 2000, 6, 2585-2597. (Pubitemid 30482092)
10. Ghobrial IM, Witzig TE, Adjei A: Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin, 2005, 55, 178-194. (Pubitemid 40826487)
11. Graner MW, Cumming RI, Binger DD: The heat shock response and chaperone/heat shock proteins in brain tumors: surface expression, release and possible immune consequences. J Neurosci, 2007, 27, 11214-11227. (Pubitemid 47621325)
12. Jakubowicz-Gil J, Rzeski W, Zdzisinska B, Dobrowolski P, Gawron A: Cell death and neuronal arborization upon quercetin treatment in rat neurons. Acta Neurobiol Exp (Wars), 2008, 68, 139-146. (Pubitemid 351871131)
13. Jankowska A, Skonieczna D, Rommerts FFC, Warchoł JB: Investigations on apoptosis in Leydig cells cultured in vitro. Folia Histochem Cytobiol, 1997, 33, 99-110.
14. Jolly C, Morimoto RI: Role of heat shock response and molecular chaperones in oncogenesis and cell death. J Nat Cancer Inst, 2000, 92, 1564-1572.
15. Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, Kominami E et al.: LC3 a mammalian homologue of yeast Apg8p is localized in autophagosome membranes after processing. EMBO J, 2000, 19, 5720-5728.
16. Kanzawa T, Germano IM, Komata T, Kondo Y, Kondo S: Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ, 2004, 11, 448-457. (Pubitemid 38489422)
17. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK: The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol, 2002, 61, 215-225. (Pubitemid 34212595)
18. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 1970, 227, 680-685.
19. Lefranc F, Facchini V, Kiss R. Proautophagic drugs: A novel means to combat apoptosis-resistant cancers, with a special emphasis on gliomas. Oncologist, 2007, 12, 1395-1403.
20. Lefranc F, Kiss R: Autophagy, the Trojan horse to combat glioblastomas. Neurosurg Focus, 2006, 20, E7.
21. Mercer LD, Kelly BL, Horne MK, Beart PM: Dietary polyphenols protect dopamine neurons from oxidative insult and apoptosis: investigations in primary rat mesencephalic cultures. Biochem Pharmacol, 2005, 69, 339-345. (Pubitemid 41556580)
22. Nair H, Rao K, Aalinkeel R, Mahajan S, Chawda R, Schwartz S: Inhibition of prostate cancer cell colony formation by the flavonoid quercetin correlates with modulation of specific regulatory genes. Clin Diagn Lab Immunol, 2004, 11, 63-69. (Pubitemid 38090653)
23. Ohgaki H, Kleihues P: Population-based studies on incidence, survival rates and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol, 2005, 64, 479-489. (Pubitemid 40781150)
24. Oliveira EJ, Watson DG, Grant MH: Metabolism of quercetin and kaempferol by rat hepatocytes and the identification of flavonoid glycosides in human plasma. Xenobiotica, 2002, 32, 279-287. (Pubitemid 34596864)
25. Omuro AM, Faivre S, Raymond E: Lessons learned in the development of targeted therapy for malignant gliomas. Mol Cancer Ther, 2007, 6, 1909-1919. (Pubitemid 47052481)
26. Perez-Vizcaino F, Duarte J, Jimenez R, Santos-Buelga C, Osuna A: Antihypertensiv effects of the flavonoid quercetin. Pharmacol Rep, 2009, 61, 67-75.
27. Ramos S: Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. J Nutr Biochem, 2007, 18, 427-442.
28. Raza SM, Lang FF, Aggarwal BB, Fuller GN, Wildrick DM, Sawaya R: Necrosis and glioblastoma: A friend or a foe? Neurosurgery, 2002, 51, 2-13.
29. 6-methylguanine. Oncogene, 2007, 26, 186-197.
30. Rosso L, Brock CS, Gallo JM, Saleem A, Price PM, Turkheimer FE, Aboagye EO: A new model for prediction of drug distribution in tumor and normal tissues: pharmacokinetinetics of temozolomide in glioma patients. Cancer Res, 2009, 69, 120-127.
31. Russo GL: Ins and outs of dietary phytochemicals in cancer chemoprevention. Biochem Pharmacol, 2007, 22, 317-320.
32. Socombining double acute accentti C, Sreedhar AS, Csermely P: Apoptosis, necrosis and cellular senescence: chaperone occupancy as a potential switch. Aging Cell, 2003, 2, 39-45.
33. Spencer JP, Kuhnle GG, Williams RJ, Rice-Evans C: Intracellular metabolism and bioactivity of quercetin and its in vivo metabolites. Biochem J, 2003, 372, 173-181. (Pubitemid 36609619)
34. Spencer JPE, Rice-Evans C, Williams RJ: Modulation of pro-survival Akt/Protein Kinase B and ERK1/2 signaling cascades by quercetin and its in vivo metabolites undrline thair action on neuronal viability. J Biol Chem, 2003, 278, 34783-34793. (Pubitemid 37102237)
35. Sreedhar AS, Csermley P: Heat shock proteins in the regulation of apoptosis: new strategies in tumor therapy. A comprehensive review. Pharm Ther, 2004, 101, 227-257.
36. Stegh AH, Kesari S, Mahoney JE, Jenq HT, Forloney KL, Protopopov A, Louis DN et al.: Bcl2L12-mediated inhibition of effector caspase-3 and caspase-7 via distinct mechanisms in glioblastoma. Proc Natl Acad Sci USA, 2008, 105, 10703-10708.
37. Takeuchi H, Kondo Y, Fujiwara K, Kanzawa T, Aoki H, Mills GB, Kondo S: Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors. Cancer Res, 2005, 65, 3336-3346. (Pubitemid 40524618)
38. Tentori L, Graziani G: Recent approaches to improve the antitumor efficacy of temozolomide. Curr Med Chem, 2009, 16, 254-257.
39. Thangasamy T, Sittadjody S, Mitchell GC, Mendoza EE, Radhakrishnan VM, Limesand KH, Burd R: Quercetin abrogates chemoresistance in melanoma cells by modulating deltaNp73. BMC Cancer, 2010, 10, 282.
40. Uzzman M, Keller G, Germano IM: Enhanced proapoptotic effects of tumor necrosis factor-related apoptosis-inducing ligand on temozolomide-resistant glioma cells. J Neurosurg, 2007, 106, 646-651. (Pubitemid 46536462)
41. Vafeiadou K, Vauzour D, Rodriguez-Mateos A, Whiteman M, Williams RJ, Spencer JPE: Glial metabolism of quercetin reduces its neurotoxic potential. Arch Biochem Biophys, 2008, 478, 195-200.
42. Vasconsuelo A, Milanesi L, Boland R: Participation of Hsp27 in the antiapoptotic action of 17 -estradiol in skeletal muscle cells. Cell Stress Chaperones, 2010, 15, 183-192.
43. Voellmy R, Boellmann F: Chaperone regulation of the heat shock protein response. Adv Exp Med Biol, 2007, 594, 89-99.
44. Youdim KA, Qaiser MZ, Begley DJ, Rice-Evans CA, Abbott NJ: Flavonoid permeability across an in situ model of the blood-brain barrier. Free Radic Biol Med, 2004, 36, 592-604. (Pubitemid 38230176)